Merit Medical Systems Pre-Paid Expenses 2010-2025 | MMSI

Merit Medical Systems pre-paid expenses from 2010 to 2025. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
  • Merit Medical Systems pre-paid expenses for the quarter ending March 31, 2025 were $0.025B, a 2.33% increase year-over-year.
  • Merit Medical Systems pre-paid expenses for 2024 were $0.029B, a 17.53% increase from 2023.
  • Merit Medical Systems pre-paid expenses for 2023 were $0.024B, a 8.79% increase from 2022.
  • Merit Medical Systems pre-paid expenses for 2022 were $0.022B, a 38.24% increase from 2021.
Merit Medical Systems Annual Pre-Paid Expenses
(Millions of US $)
2024 $29
2023 $24
2022 $22
2021 $16
2020 $13
2019 $12
2018 $11
2017 $9
2016 $6
2015 $6
2014 $5
2013 $5
2012 $4
2011 $4
2010 $2
2009 $1
Merit Medical Systems Quarterly Pre-Paid Expenses
(Millions of US $)
2025-03-31 $25
2024-12-31 $29
2024-09-30 $27
2024-06-30 $26
2024-03-31 $24
2023-12-31 $24
2023-09-30 $28
2023-06-30 $25
2023-03-31 $20
2022-12-31 $22
2022-09-30 $27
2022-06-30 $23
2022-03-31 $20
2021-12-31 $16
2021-09-30 $19
2021-06-30 $17
2021-03-31 $14
2020-12-31 $13
2020-09-30 $16
2020-06-30 $14
2020-03-31 $16
2019-12-31 $12
2019-09-30 $18
2019-06-30 $12
2019-03-31 $11
2018-12-31 $11
2018-09-30 $12
2018-06-30 $12
2018-03-31 $10
2017-12-31 $9
2017-09-30 $21
2017-06-30 $9
2017-03-31 $8
2016-12-31 $6
2016-09-30 $7
2016-06-30 $8
2016-03-31 $6
2015-12-31 $6
2015-09-30 $5
2015-06-30 $6
2015-03-31 $5
2014-12-31 $5
2014-09-30 $6
2014-06-30 $5
2014-03-31 $6
2013-12-31 $5
2013-09-30 $5
2013-06-30 $5
2013-03-31 $5
2012-12-31 $4
2012-09-30 $4
2012-06-30 $4
2012-03-31 $4
2011-12-31 $4
2011-09-30 $4
2011-06-30 $4
2011-03-31 $4
2010-12-31 $2
2010-09-30 $3
2010-06-30 $3
2010-03-31 $2
2009-12-31 $1
2009-09-30 $2
2009-06-30 $2
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $5.534B $1.357B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.300B 21.81
Becton Dickinson (BDX) United States $48.551B 12.02
Cardinal Health (CAH) United States $37.055B 19.41
Labcorp (LH) United States $20.745B 16.83
Straumann Holding AG (SAUHY) Switzerland $20.458B 0.00
West Pharmaceutical Services (WST) United States $15.044B 31.53
Cooper (COO) United States $13.399B 17.27
Align Technology (ALGN) United States $12.939B 25.68
Henry Schein (HSIC) United States $8.467B 14.52
DENTSPLY SIRONA (XRAY) United States $3.113B 9.30
CONMED (CNMD) United States $1.713B 12.82
STAAR Surgical (STAA) United States $0.827B 0.00
Lifevantage (LFVN) United States $0.157B 16.17
Pro-Dex (PDEX) United States $0.128B 14.01